Drug Approval | December 07, 2023
Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
The new ECO grade is made using renewable feedstock
Currently, Venkat is Lead – Market Access, India at Pfizer
The product has been in-licensed from Strides and will be commercialized by Amneal
The company has received Form 483 with three observations
Subscribe To Our Newsletter & Stay Updated
